COVID-19 in patients with lung cancer
Jie Luo(Memorial Sloan Kettering Cancer Center), Matthew D. Hellmann(AstraZeneca (United States)), Robert Michael Daly(Memorial Sloan Kettering Cancer Center), Kim Tien Ng(Memorial Sloan Kettering Cancer Center), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Michael Offin(Memorial Sloan Kettering Cancer Center), Afsheen N. Iqbal(Memorial Sloan Kettering Cancer Center), Adam J. Schoenfeld(Memorial Sloan Kettering Cancer Center), Marta Łuksza(Institute for Advanced Study), Jacklynn V. Egger(Memorial Sloan Kettering Cancer Center), Marjorie G. Zauderer(Memorial Sloan Kettering Cancer Center), Helena A. Yu(Memorial Sloan Kettering Cancer Center), Caroline G. McCarthy(Memorial Sloan Kettering Cancer Center), Chai Bandlamudi(Memorial Sloan Kettering Cancer Center), Mark T.A. Donoghue(Memorial Sloan Kettering Cancer Center), Mark G. Kris(Memorial Sloan Kettering Cancer Center), Kathryn C. Arbour(Memorial Sloan Kettering Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Juliana Eng(Memorial Sloan Kettering Cancer Center), David Hoyos(Memorial Sloan Kettering Cancer Center), Piro Lito(Memorial Sloan Kettering Cancer Center), Isabel R. Preeshagul(Memorial Sloan Kettering Cancer Center), A. Drilon(Memorial Sloan Kettering Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Benjamin D. Greenbaum(Memorial Sloan Kettering Cancer Center), W. Victoria Lai(AstraZeneca (United States)), Azadeh Namakydoust(Memorial Sloan Kettering Cancer Center), Jamie E. Chaft(Memorial Sloan Kettering Cancer Center), Paul K. Paik(Memorial Sloan Kettering Cancer Center), B.T. Li(Memorial Sloan Kettering Cancer Center), Christina J. Falcon(Memorial Sloan Kettering Cancer Center)
Cited by 269
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k